Literature DB >> 19471657

In reply.

Seung-Chul Yoo1, Suk-Joon Chang.   

Abstract

Year:  2008        PMID： 19471657      PMCID： PMC2676487          DOI： 10.3802/jgo.2008.19.4.280

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN： 2005-0380            Impact factor:   4.401


× No keyword cloud information.
  3 in total

1.  Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels.

Authors:  Joseph Menczer; Angela Chetrit; Siegal Sadetzki; Abraham Golan; Tally Levy
Journal:  Gynecol Oncol       Date:  2006-03-27       Impact factor: 5.482

2.  Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level.

Authors:  Basil Obeidat; John Latimer; Robin Crawford
Journal:  Gynecol Obstet Invest       Date:  2004-01-15       Impact factor: 2.031

3.  Pretreatment CA-125 and risk of relapse in advanced ovarian cancer.

Authors:  Maurie Markman; P Y Liu; Mace L Rothenberg; Bradley J Monk; Mark Brady; David S Alberts
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.